A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
New York City’s app-based delivery workers regularly face nonpayment or underpayment, unsanitary or unsafe working conditions and the risk of violence, according to a new ILR School report.
Through engaging research projects, technical lecture series, and hands-on learning, thirty students from institutions across the United States and Puerto Rico are taking their studies to the next level of research excellence.
The $3.5 million grant will go toward the improvement of screening and preventive treatment of cervical cancer for women living with HIV in low-resource countries.
A small but significant metabolic difference between human and mouse lung tumor cells has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results and pointing toward new strategies for developing cancer treatments.
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
A recent study brought together Cornell students and faculty and New York City teenagers to explore how nutrition education can improve nutrition and promote positive youth development in places with little or no access to healthy, affordable food.
Cornell’s participation in the U.S. Commerce Department initiative will help advance development and deployment of safe and trustworthy artificial intelligence technology.